Virginia bills · 2026 Regular Session
Virginia SB 486
Gluten disclaimer; required disclosures for dietary supplements and medication.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Richard H. Stuart (Republican)
Summary
Official abstract published by the Virginia legislature· SUMMARY AS PASSED SENATE
Required disclosures for dietary supplements and medication; gluten disclaimer. Requires any person who manufactures, distributes, or sells or offers for sale a dietary supplement to label such dietary supplement with a list of active and inactive ingredients and include a separate disclaimer if the product contains gluten. The bill requires pharmacists, when dispensing a prescription drug, to provide all information required under federal law to accompany the drug, including the medication guide, patient package insert, or other written patient information. The bill also requires pharmacists to provide counseling consistent with federally required labels to patients upon request when dispensing a nonprescription drug. The bill has a delayed effective date of July 1, 2027.
Text versions
Roll-call votes
State vote data last updated Oct 16, 2026, 12:24 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 9, 2026 Senate | Passage R | pass | Set your home in Virginia to see |
| Feb 5, 2026 Senate | Constitutional reading dispensed R | pass | Set your home in Virginia to see |
| Feb 4, 2026 Senate | Reported from Finance and Appropriations with substitute | pass | Set your home in Virginia to see |
| Jan 29, 2026 Senate | Reported from Education and Health | pass | Set your home in Virginia to see |
Actions
- Mar 10, 2026 · House
Left in Health and Human Services - Feb 26, 2026 · House
Subcommittee recommends continuing to 2027 (Voice Vote) - Feb 23, 2026 · House
Assigned sub: Social Services - Feb 12, 2026 · House
Referred to Committee on Health and Human Services - Feb 12, 2026 · House
Read first time - Feb 12, 2026 · House
Placed on Calendar - Feb 9, 2026 · Senate
Fiscal Impact Statement from Department of Planning and Budget (SB486) - Feb 9, 2026 · Senate
Read third time and passed Senate (40-Y 0-N 0-A) - Feb 6, 2026 · Senate
Engrossed by Senate - committee substitute Block Vote (Voice Vote) - Feb 6, 2026 · Senate
Finance and Appropriations Substitute agreed to - Feb 6, 2026 · Senate
Read second time - Feb 5, 2026 · Senate
Passed by for the day - Feb 5, 2026 · Senate
Passed by for the day (Voice Vote) - Feb 5, 2026 · Senate
Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A) - Feb 5, 2026 · Senate
Rules suspended - Feb 5, 2026 · Senate
Committee substitute printed 26107162D-S1 - Feb 4, 2026 · Senate
Senate committee offered - Feb 4, 2026 · Senate
Reported from Finance and Appropriations with substitute (15-Y 0-N) - Jan 30, 2026 · Senate
Fiscal Impact Statement from Department of Planning and Budget (SB486) - Jan 29, 2026 · Senate
Reported from Education and Health and rereferred to Finance and Appropriations (15-Y 0-N) - Jan 27, 2026 · Senate
Assigned Education sub: Health - Jan 13, 2026 · Senate
Referred to Committee on Education and Health - Jan 13, 2026 · Senate
Prefiled and ordered printed; Offered 01-14-2026 26105005D